Calidi Biotherapeutics CLDI
NYSE CLDI
$1.06 -0.01 (-0.93%)
As of: Oct 1, 2026 · 12:58 PM EDT

Calidi Biotherapeutics (CLDI) Receivables - Net (2022 - 2023)

Updated

Calidi Biotherapeutics' Receivables - Net came in at $870.00 for Q2 2023.

Analysis

Calidi Biotherapeutics (CLDI) Receivables - Net (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Calidi Biotherapeutics 1.50 Mn -23.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 870.00
Dec 31, 2022 870.00
API Access

Calidi Biotherapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=CLDI&period=max&api_key=YOUR_API_KEY